|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.342
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.312
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.273
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.270
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.268
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.238
|
|
|
|
amino acid transmembrane transport
|
GO:0003333 |
37 |
0.219
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.219
|
|
|
|
carboxylic acid transport
|
GO:0046942 |
100 |
0.217
|
|
|
|
carnitine transmembrane transport
|
GO:1902603 |
3 |
0.213
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.188
|
|
|
|
amino acid betaine transport
|
GO:0015838 |
3 |
0.183
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.183
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.177
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.176
|
|
|
|
urate transport
|
GO:0015747 |
1 |
0.157
|
|
|
|
histamine uptake
|
GO:0051615 |
1 |
0.157
|
|
|
|
potassium ion homeostasis
|
GO:0055075 |
4 |
0.153
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.150
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.145
|
|
|
|
sodium ion transport
|
GO:0006814 |
73 |
0.144
|
|
|
|
ribose phosphate biosynthetic process
|
GO:0046390 |
59 |
0.140
|
|
|
|
neutral lipid metabolic process
|
GO:0006638 |
57 |
0.137
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.135
|
|
|
|
carnitine transport
|
GO:0015879 |
3 |
0.135
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.134
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.133
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.129
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.125
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.125
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.124
|
|
|
|
carbohydrate transport
|
GO:0008643 |
62 |
0.124
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.123
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.122
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.119
|
|
|
|
cyclic purine nucleotide metabolic process
|
GO:0052652 |
43 |
0.117
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.116
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.112
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
79 |
0.110
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.109
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.106
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.104
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.103
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.102
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.101
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.101
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.100
|
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.098
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.096
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.091
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.090
|
|
|
|
epiblast cell extraembryonic ectoderm cell signaling involved in anterior posterior axis specification
|
GO:0060802 |
1 |
0.087
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.085
|
|
|
|
organic acid transport
|
GO:0015849 |
101 |
0.084
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.084
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.081
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.081
|
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
92 |
0.081
|
|
|
|
response to metal ion
|
GO:0010038 |
47 |
0.080
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.079
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.079
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.079
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.079
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.078
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.078
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.077
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.077
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.076
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.075
|
|
|
|
purine ribonucleotide biosynthetic process
|
GO:0009152 |
59 |
0.074
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.073
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.072
|
|
|
|
ribonucleotide biosynthetic process
|
GO:0009260 |
59 |
0.072
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.072
|
|
|
|
testosterone biosynthetic process
|
GO:0061370 |
2 |
0.071
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.071
|
|
|
|
feeding behavior
|
GO:0007631 |
62 |
0.069
|
|
|
|
regulation of neurotransmitter levels
|
GO:0001505 |
87 |
0.069
|
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
65 |
0.069
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.069
|
|
|
|
regulation of cyclic nucleotide metabolic process
|
GO:0030799 |
40 |
0.068
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.068
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.068
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.068
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.066
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.066
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.066
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.065
|
|
|
|
negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis
|
GO:0072040 |
4 |
0.065
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.064
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.063
|
|
|
|
digestion
|
GO:0007586 |
40 |
0.062
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.061
|
|
|
|
forelimb morphogenesis
|
GO:0035136 |
40 |
0.060
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.060
|
|
|
|
triglyceride metabolic process
|
GO:0006641 |
51 |
0.060
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.060
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.059
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.059
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.058
|
|
|
|
camp metabolic process
|
GO:0046058 |
40 |
0.058
|
|
|
|
neurotransmitter uptake
|
GO:0001504 |
14 |
0.057
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.057
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.056
|
|
|
|
regulation of ion transmembrane transporter activity
|
GO:0032412 |
54 |
0.056
|
|
|
|
acylglycerol metabolic process
|
GO:0006639 |
55 |
0.055
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.055
|
|
|
|
water transport
|
GO:0006833 |
12 |
0.054
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.054
|
|
|
|
neurotransmitter transport
|
GO:0006836 |
76 |
0.053
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.052
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.052
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.052
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.052
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.051
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.051
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.050
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.050
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.050
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.049
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.049
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.048
|
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
100 |
0.047
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.047
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.046
|
|
|
|
renal system process
|
GO:0003014 |
48 |
0.046
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.046
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.046
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.045
|
|
|
|
monocarboxylic acid transport
|
GO:0015718 |
44 |
0.044
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.044
|
|
|
|
proton transport
|
GO:0015992 |
35 |
0.043
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.043
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.043
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.042
|
|
|
|
anion transmembrane transport
|
GO:0098656 |
71 |
0.042
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.042
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.042
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
70 |
0.042
|
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
78 |
0.042
|
|
|
|
regulation of urine volume
|
GO:0035809 |
6 |
0.042
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.041
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.041
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.041
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.040
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.040
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.040
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.040
|
|
|
|
negative regulation of inflammatory response
|
GO:0050728 |
61 |
0.039
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.039
|
|
|
|
kidney mesenchymal cell proliferation
|
GO:0072135 |
2 |
0.039
|
|
|
|
cytosolic calcium ion homeostasis
|
GO:0051480 |
70 |
0.039
|
|
|
|
cyclic nucleotide biosynthetic process
|
GO:0009190 |
44 |
0.039
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.038
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.038
|
|
|
|
hydrogen transport
|
GO:0006818 |
35 |
0.038
|
|
|
|
regulation of transporter activity
|
GO:0032409 |
57 |
0.037
|
|
|
|
cell fate specification
|
GO:0001708 |
72 |
0.037
|
|
|
|
regulation of anion transport
|
GO:0044070 |
27 |
0.037
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.037
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.037
|
|
|
|
hydrogen ion transmembrane transport
|
GO:1902600 |
25 |
0.037
|
|
|
|
modified amino acid transport
|
GO:0072337 |
5 |
0.037
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.036
|
|
|
|
developmental programmed cell death
|
GO:0010623 |
41 |
0.036
|
|
|
|
cyclic nucleotide metabolic process
|
GO:0009187 |
59 |
0.036
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.036
|
|
|
|
l amino acid transport
|
GO:0015807 |
32 |
0.036
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.035
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.035
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.035
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.035
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.035
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.034
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.034
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.034
|
|
|
|
glucose transport
|
GO:0015758 |
56 |
0.034
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.033
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.033
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.033
|
|
|
|
tendon formation
|
GO:0035992 |
4 |
0.032
|
|
|
|
renal tubule development
|
GO:0061326 |
87 |
0.032
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.032
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.031
|
|
|
|
androgen biosynthetic process
|
GO:0006702 |
4 |
0.031
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.031
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.031
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.031
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.031
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.031
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.031
|
|
|
|
regulation of chloride transport
|
GO:2001225 |
2 |
0.031
|
|
|
|
alpha amino acid metabolic process
|
GO:1901605 |
59 |
0.031
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.031
|
|
|
|
intestinal absorption
|
GO:0050892 |
13 |
0.030
|
|
|
|
tendon cell differentiation
|
GO:0035990 |
4 |
0.030
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.030
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.029
|
|
|
|
polarity specification of proximal distal axis
|
GO:0010085 |
2 |
0.029
|
|
|
|
left lung development
|
GO:0060459 |
4 |
0.029
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.029
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.029
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.029
|
|
|
|
monovalent inorganic cation homeostasis
|
GO:0055067 |
33 |
0.029
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.029
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.029
|
|
|
|
transforming growth factor beta receptor signaling pathway involved in primitive streak formation
|
GO:0090010 |
1 |
0.029
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.029
|
|
|
|
negative regulation of synapse maturation
|
GO:2000297 |
2 |
0.029
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.029
|
|
|
|
spinal cord development
|
GO:0021510 |
81 |
0.028
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.028
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.028
|
|
|
|
regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis
|
GO:0072039 |
4 |
0.028
|
|
|
|
axon ensheathment
|
GO:0008366 |
76 |
0.028
|
|
|
|
alcohol biosynthetic process
|
GO:0046165 |
43 |
0.028
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.028
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.027
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.027
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.027
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.027
|
|
|
|
potassium ion transmembrane transport
|
GO:0071805 |
43 |
0.027
|
|
|
|
trophectodermal cellular morphogenesis
|
GO:0001831 |
3 |
0.027
|
|
|
|
kidney morphogenesis
|
GO:0060993 |
83 |
0.027
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.027
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.026
|
|
|
|
cellular transition metal ion homeostasis
|
GO:0046916 |
32 |
0.026
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.026
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.026
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.026
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.026
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.026
|
|
|
|
regulation of feeding behavior
|
GO:0060259 |
3 |
0.026
|
|
|
|
roof plate formation
|
GO:0021509 |
1 |
0.026
|
|
|
|
regulation of appetite
|
GO:0032098 |
12 |
0.026
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.025
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.025
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.025
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.025
|
|
|
|
hexose transport
|
GO:0008645 |
56 |
0.025
|
|
|
|
regulation of nucleotide biosynthetic process
|
GO:0030808 |
34 |
0.025
|
|
|
|
body fluid secretion
|
GO:0007589 |
53 |
0.025
|
|
|
|
cellular response to metal ion
|
GO:0071248 |
31 |
0.025
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.025
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.025
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.024
|
|
|
|
hormone biosynthetic process
|
GO:0042446 |
16 |
0.024
|
|
|
|
regulation of cyclic nucleotide biosynthetic process
|
GO:0030802 |
31 |
0.024
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.024
|
|
|
|
monosaccharide transport
|
GO:0015749 |
58 |
0.024
|
|
|
|
phenol containing compound metabolic process
|
GO:0018958 |
60 |
0.024
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.024
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.024
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.024
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.024
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.023
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.023
|
|
|
|
renal water homeostasis
|
GO:0003091 |
7 |
0.023
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.023
|
|
|
|
regulation of transcription from rna polymerase ii promoter involved in determination of left right symmetry
|
GO:1900094 |
2 |
0.022
|
|
|
|
amino acid transport
|
GO:0006865 |
61 |
0.022
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.022
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.022
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.022
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.022
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.022
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
82 |
0.022
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.021
|
|
|
|
response to calcium ion
|
GO:0051592 |
20 |
0.021
|
|
|
|
lipid homeostasis
|
GO:0055088 |
63 |
0.021
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.021
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.021
|
|
|
|
nephrogenic mesenchyme development
|
GO:0072076 |
3 |
0.021
|
|
|
|
metanephros development
|
GO:0001656 |
79 |
0.021
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
77 |
0.021
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.021
|
|
|
|
negative regulation of peptidase activity
|
GO:0010466 |
46 |
0.021
|
|
|
|
endochondral bone morphogenesis
|
GO:0060350 |
50 |
0.021
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.021
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.021
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.021
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.021
|
|
|
|
hexose transmembrane transport
|
GO:0035428 |
7 |
0.021
|
|
|
|
pancreatic pp cell fate commitment
|
GO:0003329 |
2 |
0.021
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.021
|
|
|
|
regulation of response to food
|
GO:0032095 |
10 |
0.020
|
|
|
|
mitral valve development
|
GO:0003174 |
4 |
0.020
|
|
|
|
monoamine transport
|
GO:0015844 |
33 |
0.020
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.020
|
|
|
|
transition metal ion transport
|
GO:0000041 |
38 |
0.020
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.020
|
|
|
|
endothelium development
|
GO:0003158 |
45 |
0.020
|
|
|
|
male gonad development
|
GO:0008584 |
88 |
0.020
|
|
|
|
regulation of organ growth
|
GO:0046620 |
61 |
0.020
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.020
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.020
|
|
|
|
mammary gland duct morphogenesis
|
GO:0060603 |
38 |
0.020
|
|
|
|
response to drug
|
GO:0042493 |
75 |
0.020
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.019
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.019
|
|
|
|
auditory receptor cell differentiation
|
GO:0042491 |
37 |
0.019
|
|
|
|
protein kinase c activating g protein coupled receptor signaling pathway
|
GO:0007205 |
4 |
0.019
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.019
|
|
|
|
pancreatic a cell fate commitment
|
GO:0003326 |
2 |
0.019
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.019
|
|
|
|
phenol containing compound biosynthetic process
|
GO:0046189 |
21 |
0.019
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.019
|
|
|
|
multicellular organismal water homeostasis
|
GO:0050891 |
23 |
0.019
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.019
|
|
|
|
intestinal epithelial cell maturation
|
GO:0060574 |
2 |
0.019
|
|
|
|
metanephric loop of henle development
|
GO:0072236 |
4 |
0.019
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.019
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.019
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.019
|
|
|
|
lung morphogenesis
|
GO:0060425 |
50 |
0.019
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.019
|
|
|
|
astrocyte fate commitment
|
GO:0060018 |
4 |
0.018
|
|
|
|
camp biosynthetic process
|
GO:0006171 |
31 |
0.018
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.018
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.018
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.018
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.018
|
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
88 |
0.018
|
|
|
|
regulation of cardiac cell fate specification
|
GO:2000043 |
1 |
0.018
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.018
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.018
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.018
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.018
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.018
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.018
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.018
|
|
|
|
cellular potassium ion transport
|
GO:0071804 |
43 |
0.018
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.018
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.017
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.017
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.017
|
|
|
|
negative regulation of protein transport
|
GO:0051224 |
46 |
0.017
|
|
|
|
forebrain generation of neurons
|
GO:0021872 |
63 |
0.017
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.017
|
|
|
|
nodal signaling pathway involved in determination of left right asymmetry
|
GO:0038107 |
2 |
0.017
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.017
|
|
|
|
potassium ion transport
|
GO:0006813 |
52 |
0.017
|
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.017
|
|
|
|
nodal signaling pathway involved in determination of lateral mesoderm left right asymmetry
|
GO:1900164 |
2 |
0.017
|
|
|
|
dephosphorylation
|
GO:0016311 |
129 |
0.017
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.017
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.017
|
|
|
|
regulation of t cell proliferation
|
GO:0042129 |
92 |
0.017
|
|
|
|
response to corticosterone
|
GO:0051412 |
1 |
0.017
|
|
|
|
sensory perception of pain
|
GO:0019233 |
47 |
0.017
|
|
|
|
adenylate cyclase modulating g protein coupled receptor signaling pathway
|
GO:0007188 |
54 |
0.017
|
|
|
|
trachea cartilage morphogenesis
|
GO:0060535 |
4 |
0.017
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.017
|
|
|
|
inner ear receptor cell differentiation
|
GO:0060113 |
61 |
0.017
|
|
|
|
spinal cord oligodendrocyte cell fate specification
|
GO:0021530 |
3 |
0.017
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.017
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.016
|
|
|
|
energy reserve metabolic process
|
GO:0006112 |
39 |
0.016
|
|
|
|
axial mesodermal cell fate commitment
|
GO:0048322 |
1 |
0.016
|
|
|
|
hair cell differentiation
|
GO:0035315 |
40 |
0.016
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.016
|
|
|
|
coenzyme metabolic process
|
GO:0006732 |
52 |
0.016
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.016
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.016
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.016
|
|
|
|
regulation of saliva secretion
|
GO:0046877 |
2 |
0.016
|
|
|
|
negative regulation of stem cell maintenance
|
GO:1902455 |
4 |
0.016
|
|
|
|
somatic stem cell maintenance
|
GO:0035019 |
47 |
0.016
|
|
|
|
positive regulation of gliogenesis
|
GO:0014015 |
27 |
0.016
|
|
|
|
regulation of purine nucleotide biosynthetic process
|
GO:1900371 |
34 |
0.016
|
|
|
|
regulation of multicellular organismal metabolic process
|
GO:0044246 |
14 |
0.016
|
|
|
|
sodium ion transmembrane transport
|
GO:0035725 |
49 |
0.016
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.016
|
|
|
|
iron ion homeostasis
|
GO:0055072 |
36 |
0.016
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.016
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.016
|
|
|
|
amino acid betaine metabolic process
|
GO:0006577 |
7 |
0.016
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.016
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.016
|
|
|
|
apoptotic process involved in development
|
GO:1902742 |
28 |
0.016
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.016
|
|
|
|
carbohydrate catabolic process
|
GO:0016052 |
32 |
0.016
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.016
|
|
|
|
brain segmentation
|
GO:0035284 |
3 |
0.016
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.016
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.016
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.016
|
|
|
|
regulation of cardioblast differentiation
|
GO:0051890 |
3 |
0.016
|
|
|
|
ascending thin limb development
|
GO:0072021 |
2 |
0.016
|
|
|
|
lung epithelial cell differentiation
|
GO:0060487 |
29 |
0.015
|
|
|
|
regulation of inward rectifier potassium channel activity
|
GO:1901979 |
1 |
0.015
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.015
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.015
|
|
|
|
glycerophospholipid metabolic process
|
GO:0006650 |
71 |
0.015
|
|
|
|
subpallium neuron fate commitment
|
GO:0060163 |
2 |
0.015
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.015
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.015
|
|
|
|
hippocampus development
|
GO:0021766 |
52 |
0.015
|
|
|
|
kidney mesenchyme morphogenesis
|
GO:0072131 |
4 |
0.015
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.015
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.015
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.015
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.015
|
|
|
|
liver development
|
GO:0001889 |
66 |
0.015
|
|
|
|
notch signaling pathway
|
GO:0007219 |
71 |
0.015
|
|
|
|
ventricular cardiac muscle cell development
|
GO:0055015 |
11 |
0.015
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.015
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.015
|
|
|
|
c21 steroid hormone biosynthetic process
|
GO:0006700 |
3 |
0.015
|
|
|
|
positive regulation of urine volume
|
GO:0035810 |
6 |
0.015
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.015
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.015
|
|
|
|
nephron tubule development
|
GO:0072080 |
84 |
0.015
|
|
|
|
mesenchymal cell apoptotic process involved in nephron morphogenesis
|
GO:1901145 |
4 |
0.015
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.015
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.014
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.014
|
|
|
|
neural crest cell development
|
GO:0014032 |
48 |
0.014
|
|
|
|
carnitine metabolic process
|
GO:0009437 |
7 |
0.014
|
|
|
|
positive regulation of purine nucleotide biosynthetic process
|
GO:1900373 |
26 |
0.014
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.014
|
|
|
|
brown fat cell differentiation
|
GO:0050873 |
36 |
0.014
|
|
|
|
mechanoreceptor differentiation
|
GO:0042490 |
67 |
0.014
|
|
|
|
brain morphogenesis
|
GO:0048854 |
32 |
0.014
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.014
|
|
|
|
collecting duct development
|
GO:0072044 |
11 |
0.014
|
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.014
|
|
|
|
lens development in camera type eye
|
GO:0002088 |
62 |
0.014
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.014
|
|
|
|
determination of left right symmetry
|
GO:0007368 |
80 |
0.014
|
|
|
|
regulation of antigen receptor mediated signaling pathway
|
GO:0050854 |
29 |
0.014
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.014
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.014
|
|
|
|
regulation of camp metabolic process
|
GO:0030814 |
30 |
0.014
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.014
|
|
|
|
negative regulation of keratinocyte differentiation
|
GO:0045617 |
4 |
0.014
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.014
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.014
|
|
|
|
positive regulation of camp mediated signaling
|
GO:0043950 |
3 |
0.014
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.014
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.014
|
|
|
|
glucose metabolic process
|
GO:0006006 |
92 |
0.014
|
|
|
|
somatostatin signaling pathway
|
GO:0038170 |
2 |
0.014
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.014
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.014
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.014
|
|
|
|
fluid transport
|
GO:0042044 |
14 |
0.014
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.014
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.014
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.014
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.014
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.014
|
|
|
|
multi organism behavior
|
GO:0051705 |
62 |
0.014
|
|
|
|
embryonic digit morphogenesis
|
GO:0042733 |
56 |
0.014
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.014
|
|
|
|
cell differentiation in spinal cord
|
GO:0021515 |
53 |
0.014
|
|
|
|
hypophysis morphogenesis
|
GO:0048850 |
3 |
0.014
|
|
|
|
renal sodium ion transport
|
GO:0003096 |
2 |
0.014
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.014
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.014
|
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
103 |
0.014
|
|
|
|
terpenoid metabolic process
|
GO:0006721 |
25 |
0.013
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.013
|
|
|
|
regulation of notch signaling pathway
|
GO:0008593 |
35 |
0.013
|
|
|
|
metanephric mesenchyme morphogenesis
|
GO:0072133 |
4 |
0.013
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.013
|
|
|
|
mesendoderm development
|
GO:0048382 |
3 |
0.013
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.013
|
|
|
|
immune response activating cell surface receptor signaling pathway
|
GO:0002429 |
72 |
0.013
|
|
|
|
response to iron ion
|
GO:0010039 |
4 |
0.013
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.013
|
|
|
|
response to mineralocorticoid
|
GO:0051385 |
1 |
0.013
|
|
|
|
multicellular organismal aging
|
GO:0010259 |
24 |
0.013
|
|
|
|
vitamin d biosynthetic process
|
GO:0042368 |
3 |
0.013
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.013
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.013
|
|
|
|
defense response to gram negative bacterium
|
GO:0050829 |
28 |
0.013
|
|
|
|
cholesterol homeostasis
|
GO:0042632 |
44 |
0.013
|
|
|
|
neuromuscular process
|
GO:0050905 |
99 |
0.013
|
|
|
|
positive regulation of tendon cell differentiation
|
GO:2001051 |
1 |
0.013
|
|
|
|
regulation of steroid metabolic process
|
GO:0019218 |
39 |
0.013
|
|
|
|
activation of adenylate cyclase activity
|
GO:0007190 |
4 |
0.013
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.013
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.013
|
|
|
|
diencephalon development
|
GO:0021536 |
63 |
0.013
|
|
|
|
cellular response to prostaglandin stimulus
|
GO:0071379 |
2 |
0.013
|
|
|
|
positive regulation of erk1 and erk2 cascade
|
GO:0070374 |
47 |
0.013
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.013
|
|
|
|
small molecule catabolic process
|
GO:0044282 |
71 |
0.012
|
|
|
|
l alpha amino acid transmembrane transport
|
GO:1902475 |
23 |
0.012
|
|
|
|
glial cell development
|
GO:0021782 |
54 |
0.012
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.012
|
|
|
|
urea transport
|
GO:0015840 |
4 |
0.012
|
|
